PAREXEL International Corporation (NASDAQ:PRXL) will speak at the 19th Annual Oppenheimer Healthcare Conference in
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical services company, providing a range of capability in clinical research, medical communications services, consulting, and informatics and technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
The Company’s product and service offerings include clinical trials management, data management, biostatistical analysis, medical communications services, clinical pharmacology, patient recruitment, regulatory and product development consulting, health policy and reimbursement, performance improvement, industry training and publishing, medical imaging services, interactive voice response systems (IVRS), clinical trial management systems (CTMS), Web-based portals, systems integration, patient diary applications, and other drug development services. In August 2008, PAREXEL completed the acquisition of ClinPhone plc.
Read more Business News on The Global Market Directory.
About The Global Market Directory (TheGMD)
TheGMD is a financial networking community for Public Companies, Brokerage Firms, Stock Brokers and Individuals. Members can network and link with each other, participate in discussions on financial stock message boards, display pictures and upload videos.
The GMD is a member of the TransWorldNews, Inc. family of sites. Members can distribute press releases through The GMD and receive distribution over all TransWorldNews news outlets.
Create your profile on The Global Market Directory